ctrl K

Watchlist Price Alert

Prime Medicine Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

2.48

0.02 (0.81%)

At close: Jun 25, 2025, 9:42 AM

Prime Medicine Revenue Breakdown

Period Ending	Dec 31, 2024
Reportable Segment Revenue	2.98M
Reportable Segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General, and Administrative Revenue	13.28M	12.3M	14.1M	12.6M	11.16M	13.08M	10.49M	10.66M	9.15M	9.63M	6.61M	7.37M	6.22M	7.19M	3.03M	2.32M	1.39M	1.25M	1.25M
Selling, General, and Administrative Revenue Growth	+7.99%	-12.77%	+11.90%	+12.93%	-14.72%	+24.70%	-1.56%	+16.44%	-4.90%	+45.66%	-10.28%	+18.39%	-13.44%	+137.43%	+30.42%	+67.10%	+10.94%	0.00%	n/a
Research and Development Revenue	40.56M	34.1M	40.34M	43.07M	37.77M	41.46M	40.97M	34.6M	30.88M	29.06M	25.05M	18.94M	13.68M	52.89M	7.4M	5.7M	4.57M	920K	920K
Research and Development Revenue Growth	+18.94%	-15.46%	-6.34%	+14.02%	-8.89%	+1.20%	+18.41%	+12.04%	+6.26%	+16.03%	+32.24%	+38.48%	-74.14%	+614.72%	+29.94%	+24.73%	+396.30%	0.00%	n/a